10-year trial of melanoma vaccine shows most promising outcomes to date

Researchers at the University of Adelaide have discovered a new trial vaccine which offers the most promising treatment to date for advanced melanoma.

Known as ‘vaccinia melanoma cell lysate’ (VMCL), this new trial treatment was given regularly to 54 South Australian patients with advanced, inoperable melanoma over a 10-year period. The vaccine has been found to increase patient survival rates, with the ability to stop or reverse the cancer in some patients.

Continue reading “10-year trial of melanoma vaccine shows most promising outcomes to date”

2009 Grant Recipients Announced

The winners of the ACRF latest research grants are:

Children’s Medical Research Institute (CMRI) & University of Newcastle NSW: $3.1 million

To build and equip two dedicated laboratories for the world’s first Chemical Proteomics Centre for Kinomics. This is a new discipline, merging genomics (genes) and proteomics (proteins) implicated in certain human cancers and is a priority area for new drug targets.

The Centre for Cancer Biology (CCB), South Australian Pathology and the University of Adelaide: $3.5 million

For equipment to establish a new Cancer Genomics Facility, enabling researchers to obtain insights into genetic modifications that underpin development of new tools for better diagnostics, disease prognosis, drug response, and resistance to chemotherapy.

Biggest ever private grant the catalyst for leading edge cancer research in Adelaide

Adelaide scientists are well positioned to further cement their position as national and international leaders in cancer research, following today’s opening of the Adelaide Proteomics Centre at the University of Adelaide.

The world-class $3million Proteomics Centre in the University’s School of Molecular and Biomedical Science – the only one of its kind in South Australia – was opened by Jennifer Rankine, Parliamentary Secretary to South Australian Premier, Mike Rann.

The Centre was built and equipped with the support of a $1.5million grant from the Australian Cancer Research Foundation (ACRF) – the biggest ever private foundation research grant awarded in South Australia. It is also the largest individual grant awarded by the Foundation in its 21 year history. It is also the biggest ever private grant awarded by the foundation.

Dr Peter Hoffman, an internationally-renowned Proteomics specialist, has been recruited to Adelaide to direct the centre.

Continue reading “Biggest ever private grant the catalyst for leading edge cancer research in Adelaide”